Bundle of investment news: covid drug, PayPal and Call of Duty record

Reports my reports

У PayPal (Nasdaq: PYPL) reporting broke all records again: revenue increased by twenty-nine percent - to 6,03 billion, and profit - by 1206%, to 1,097 billion. Excluding one-time tax deduction, profit increased by 3 Times, which is also cool enough. Taking into account the growing popularity of cashless payments (and adding the ability to use digital currency by the company), Formerly?? obvious even before a strong epidemic, you can wait for that, that growth will continue: over the year, the amount of payments on the company's site increased by fifty percent - up to 285,477 billion.

Fintech startup Square (NYSE: SQ) revenue grew by almost 4 times - largely due to the growth of bitcoin transactions by almost 12 once. Other segments showed much more moderate levels of improvement. In terms of income, everything is also extremely good.: last year's loss 105,891 million changed in profit 39 million. Basically, lovers of cryptographic currencies should not rejoice: the company's bitcoin business does not differ in marginality.

Volkswagen (VOW3.DE) increased revenue by 13,3 %, and profit from 517 million to 3,414 billion euros. The indicators turned out to be better than the expectations of specialists, And, which is especially important, sales of electric vehicles doubled. Eventually, electrification of road transport is becoming more common: if such mainstream car factories like VW prioritize electric cars - and the company plans to build 6 factories for the production of electric batteries, — that «not ele-ele, but seriously, the carousel is spinning ", in the line of the "Krovostok" group.

BMW (BMW @ DE) also shows a good result and is recovering from the coronacrisis harm: revenue increased from 23,252 to 26,778 billion euros, profits increased in 5 unnecessarily - up to 2,833 billion euros. Sales increased in almost all major markets, not counting, actually, GERMANY (−6,4 %), Spain (−14%) and UK (−12%).

Uber (NYSE: UBER) presented a report on the fall in revenue by eleven percent, what well, taking into account the situation with covid restrictions. To a significant extent, the fall is justified by waste 600 million in UK per drivers: their company is obliged to count as full-time employees with all accompanying expenses. Without it, revenue increased by eight percent. The total number of reservations on the site grew by twenty-four percent, in almost everything due to an increase in 166% in the food delivery sector and fifty-two percent in the cargo delivery sector; the number of travel reservations fell by thirty-eight percent. However, the company had no income, and it doesn't: operating loss in the current year was 1,524 billion, a year ago was 1,263 billion.

  The POMOs

У Booking Holdings (Nasdaq: BKNG), whose business depends on the free movement of people, revenue almost doubled. Operating loss increased slightly - from 309 to 311 million, but the total loss decreased by almost 14 once - to 55 million, thanks to a one-time tax deduction. Indicators turned out to be slightly better than expected, however, it is not clear to me for sure, how anyone can have any expectations for this company, if the world has a real travel ban for the vast majority of residents. Basically, judging by the news of the slow and painful opening of tourist destinations within the United States, which heading quarter might turn out to be a bit better.

Anheuser-Busch InBev (NYSE: BUD) increased revenue by 17,2 %, and last year's loss 2,141 billion changed in profit 892 million dollars. Calculation for that, that the desperation and sliding into poverty of hundreds of millions of people around the world will lead to an increase in the use of alcoholic beverages, justified: the total size of the company's products sold increased by 13,3 %.

Twilio (NYSE: TWLO) boasts a sixty-two percent increase in revenue, but losses there grow and widen - with 94,791 to 206,542 million. The result turned out to be better than expected, but the increase in the company's revenue forecast for the next quarter does not change the fact, that the company expects a bigger loss, if experts counted. well, ordinary startup story, what else to say here.

CVS Health Corp (NYSE: CVS) boasts an increase in revenue by three and a half percent - up to 69,1 billion, income - from 2,012 to 2,224 billion. This is a pretty cool result - and better than expected, taking into account the decrease in the mobility of residents in the United States in the face of a new portion of covid restrictions. The company also improved its forecast for the current year..

Zoetis (NYSE: ZTS) reported revenue growth 22% - to 1,9 billion and profit by 32% - to 559 million. It is worth noting, that the company's international sales segment is growing faster, than American: on 27% against 19%. The company also improved its forecast for 2021 year.

У Activision Blizzard (NASDAQ: ATV) revenue increased from 1,788 to 2,275 billion, and profit from 505 to 619 million. In many ways, these results were made possible thanks to the successful - and completely inexplicable for all people with good taste - the release of Call of Duty: Black Ops Cold War and more powerful, than usual, growth of performance of the mobile division. The results were better than expected, and at the end of the year, the company also raised its forecast.

  Worth reading and listening to

Adidas (ADS@DE) showed revenue growth by 20,2% - to 5,268 billion euros, and the profit has grown by as much 2056%. Such rampant growth is due to, certainly, not the great genius of company management, but just the, that a year ago her business was knocked out due to coronavirus restrictions. So what's the point, rather, about returning to normal. However, this report does not include the drop in sales by 78% in China. The company suffered from the boycott in China, caused by her defiant rejection of cotton from Xinjiang, - we talked about this story in more detail. So find out about, how the anger of Chinese consumers affected the company's sales, we can only in the next quarter.

У General Motors (NYSE: GM) revenue fell slightly - from 32,709 to 32,474 billion, but the profit increased by almost 11 once - to 3,014 billion. The result was better than expected, but the company did not raise its forecast for 2021 year for one simple reason: the lack of semiconductors slows down the production of new machines and does not allow to take full advantage of opportunities, provided by growing demand, - Factories have to be shut down, because vital components were not delivered.

Infineon (IFX @ DE) reported an increase in revenue 36%, to 2,7 billion euros, and arrived at 14%, to 203 million, with sales growth in all segments. But, like GM, the company suffers from a lack of components, because of which its production capacity remains underutilized.

У Sysco (NYSE: SYY) sales fell by 13,7% due to the continued closure of many catering establishments. But thanks to the active management policy, last year's loss 3,297 million changed to profit 88,927 million including 12,7 million of inappropriate income. Considering, that the restaurant industry in the United States began to revitalize, I would expect a relative improvement in the situation for the company in the next quarter.

Roku streaming company (NASDAQ: YEAR) showed revenue growth by 79% and improved profits: lesion 54,612 million changed to profit 76,296 million. To a large extent, this improvement was due to the growth of the company's revenue from the platform - this is a much more marginal business., rather than selling turntables.

У AbbVie (NYSE: ABBV) revenue increased by 51%, and profits have grown since 3,01 billion to 3,553 billion. Sales growth was in all segments, except for "Humira", - this drug has competitors-analogues, which led to a drop in revenue in this segment by 8,3%.

  What a goal!!!!

And about vaccination

Let's talk separately about several pharmaceutical issuers, united by a common coronavirus theme.

У Pfizer (NYSE: PFE) revenue and profit increased by 45% largely due to sales of the coronavirus vaccine - without it, growth would have been 8%. Although in general growth was in all segments. The results were better than expected, the company improved its outlook for the year.

Regeneron (NASDAQ: RAIN) reported an increase in revenue 38% and arrived at 78% - excluding one-time non-core income, profit increased by 44%, which is also very good. To a large extent, this result is caused by an increase in sales of drugs for coronavirus in 20%. The company also announced that it has received regulatory approval for a number of its drugs, which means, that the company will be able to expand the line of drugs sold in the near future.

Modern (NASDAQ: MRNA) finally entered the commercial phase - and how did! With proceeds 1,937 billion the company's total profit 1,221 billion against loss 124 million a year earlier - the company successfully capitalized on the sale of its coronavirus drug. And here we come to a very difficult moment..

More and more governments, including USA, want to temporarily cancel the patent protection of coronavirus vaccines, to facilitate their production and distribution. This, Certainly, hit the companies mentioned above. But in a different way. Regeneron has less COVID-19 cure 10% proceeds. Pfizer's coronavirus vaccine accounts for about a quarter of its sales. So these companies will survive the abolition of patent protection without monstrous losses.. But at Moderna, all sales are just given by the coronavirus vaccine - so if the plan is implemented, the company will suffer the most.

But it's important to understand, that the effect of canceling patents will not be felt immediately: all companies have already signed contracts for several years ahead at a fixed price, and the very fact of cancellation of patents does not mean, that alternatives will quickly appear, - and the states need them just quickly. So it's more about, that their ability to generate windfall profits from vaccines will be somewhat limited.

Scroll to Top